Mehandru and Merad reviewed the many clinical manifestations of long-haul COVID, including systemic and musculoskeletal manifestations (chronic fatigue and fibromyalgia symptoms), psychiatric symptoms (insomnia, depression, anxiety, neurocognitive deficits), autonomic and cardiovascular, GIS and renal and respiratory manifestations [71]
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, modulates hunger signals rather than eliminating them entirely
After 12 months of GLP-1 therapy with diet and exercise optimization: weight drops to 205 pounds
People with alcohol dependence or chronic illnesses Those taking certain medications that interfere with B12 absorption, including metformin and proton pump inhibitors
Our research underscores that the full benefit will come from going beyond medication